Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Azenta (AZTA)
NASDAQ:AZTA
Earnings Data
Report Date
May 12, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
0.07Last Year’s EPS
0.05Same Quarter Last Year
Moderate Buy
Based on 4 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:Feb 05, 2025
|% Change Since: -13.89%
|Next Earnings Date:May 12, 2025
Earnings Call Sentiment|Positive
The earnings call reflected a cautiously optimistic outlook for fiscal year 2025, with several positive developments in the company's operations and financial health. Despite a few challenges, such as declining Sanger Sequencing revenue and uncertainties in large stores revenue, the company maintains a strong cash position and has shown significant operational improvements. The overall sentiment of the call is positive, given the strong financial performance and strategic initiatives underway.Company Guidance
During the Azenta Q1 2025 Financial Results Conference Call, the company provided guidance on key metrics for fiscal year 2025. Azenta projects organic revenue growth between 3% and 5% for the full year, with the Sample Management Solutions segment expected to grow mid-single digits and Multiomics segment to grow low single digits. The company also anticipates a 300 basis point expansion in adjusted EBITDA margin. In Q1, Azenta reported a 4% year-over-year organic revenue growth, with an adjusted EBITDA margin expansion of 400 basis points. The company continues to focus on operational excellence and portfolio optimization, aiming to enhance profitability and long-term shareholder value.Positive Start to Fiscal Year 2025
Fiscal 2025 started with positive momentum, with organic revenue growing by 4% year-over-year and adjusted EBITDA margin expanding by 400 basis points.
Multiomics Business Growth
The Multiomics segment reported a 6% growth year-over-year, with Next Generation Sequencing growing by 11% and Gene Synthesis by 5%.
Strong Cash Position
Azenta ended the quarter with $530 million in cash, cash equivalents, and marketable securities, demonstrating strong financial health.
Operational Improvements
Gross margin increased by 270 basis points year-over-year, and adjusted EBITDA margin improved by 400 basis points, indicating better operational efficiencies.
---
AZTA Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
AZTA Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
| Feb 05, 2025 | $51.97 | $53.76 | +3.44% |
| Nov 12, 2024 | $45.99 | $44.51 | -3.22% |
| Aug 06, 2024 | $58.34 | $53.13 | -8.93% |
| May 08, 2024 | $54.07 | $52.51 | -2.89% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does Azenta (AZTA) report earnings?
Azenta (AZTA) is schdueled to report earning on May 12, 2025, TBA Not Confirmed.
What is Azenta (AZTA) earnings time?
Azenta (AZTA) earnings time is at May 12, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is AZTA EPS forecast?
AZTA EPS forecast for the fiscal quarter 2025 (Q2) is 0.07.
---
